The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A
about
Transcriptional up-regulation of the delayed early gene HRS/SRp40 during liver regeneration. Interactions among YY1, GA-binding proteins, and mitogenic signalsHuman immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2SRp30c is a repressor of 3' splice site utilization.Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor geneIdentification and characterization of a novel serine-arginine-rich splicing regulatory proteinRoles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulationFinding signals that regulate alternative splicing in the post-genomic eraDepletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphismsIsolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognitionAlternative splicing of intron 3 of the serine/arginine-rich protein 9G8 gene. Identification of flanking exonic splicing enhancers and involvement of 9G8 as a trans-acting factorSerine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor beta in neutrophilsDifferential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNAA purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNASplicing of two internal and four carboxyl-terminal alternative exons in nonmuscle tropomyosin 5 pre-mRNA is independently regulated during developmentRegulation of a novel isoform of Receptor Expression Enhancing Protein REEP6 in rod photoreceptors by bZIP transcription factor NRLThe RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice siteCharacterization of tissue-specific and developmentally regulated alternative splicing of exon 64 in the COL5A1 geneConserved proline-directed phosphorylation regulates SR protein conformation and splicing functionAntagonistic factors control the unproductive splicing of SC35 terminal intron.Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exonsCharacterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogeneUtilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers.The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing.Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.Distinctive features of Drosophila alternative splicing factor RS domain: implication for specific phosphorylation, shuttling, and splicing activationVitamin A metabolite, all-trans-retinoic acid, mediates alternative splicing of protein kinase C deltaVIII (PKCdeltaVIII) isoform via splicing factor SC35.A unique glutamic acid-lysine (EK) domain acts as a splicing inhibitor.Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNAThe splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expressionSC35 autoregulates its expression by promoting splicing events that destabilize its mRNAsRNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liverTropomyosin-based regulation of the actin cytoskeleton in time and space.Functional characterization of SR and SR-related genes in Caenorhabditis elegans.A novel actin mRNA splice variant regulates ACTG1 expression.The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the beta-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunitConcentration dependent selection of targets by an SR splicing regulator results in tissue-specific RNA processing.
P2860
Q22008556-8ABCECFB-8FB8-4FCD-975F-92D5B638C9E8Q24305530-6206B4E0-C3E8-40BC-A3F4-C0BD1436B764Q24537431-3F53395F-73B2-4208-98D1-23CF4A89FFDBQ24545614-D1CE05BD-5480-4A6C-A2EA-2A2BC1DB4306Q24554250-F9946215-3044-424F-A0A1-C35B7A9BF06EQ24684890-E49F5AF0-7EC3-42EF-9388-BF833C3C761CQ24806394-DEB9309C-8225-44B7-A874-C86CB17CA232Q24811044-810F8EFD-C41A-448D-84D0-4E2764AA6498Q25257572-6E05B610-446D-4B5C-B730-D899BC68C05BQ27678986-262FC202-314D-4E61-BA1C-0D88EF2D1CB9Q28138789-BA28F5FA-92CC-4CBD-84FB-1CFE99D9A441Q28203376-7D260CA6-6369-41AA-9632-6ECC8238FAB8Q28259926-8FB15248-8B71-4ABF-A628-C51F1FC12357Q28367479-EAE5F237-F84D-4A2B-AF9F-3B5ECAF66E2DQ28580638-B0CCC051-E9A1-4465-88BB-7DBDF5295962Q28589672-F0AA53BC-2D5B-4CAD-BF57-56166A6DAEFEQ28609616-5EC378DA-893B-4F8C-B5FE-E246E74F7F92Q28658325-074ED911-EFC6-4758-992F-F1AFCE4DE716Q28822425-B65EC043-3F6C-4C93-813E-E51E82084CCCQ30493457-7378EB62-4DA7-428A-836C-BBA4205FC6D3Q30655740-ECDE44A7-E39F-4911-BE0D-445FC97ECAADQ33776427-D7CAF5D6-8316-40F0-A639-AB2D53CED3CAQ33787297-6EFD3BA1-4249-4DD8-8B6F-EE854A5CFF5DQ33935979-BA09F5E2-0DA0-4FFD-9CE6-B4EF345D8FF2Q33959780-A8345ADC-0D26-4ADD-8884-FC8AC3E0B225Q33959923-07DB20C5-4B46-4E13-BBE8-ACCE05E98AC7Q34011664-3894B3D4-3A3C-47A4-860A-064361914D06Q34074258-86CBB892-D61A-4186-83D7-4EE9866BA239Q34144919-2213AFF0-B041-43DB-ADDF-E8C6FFF38A07Q34361795-A126D752-34F3-44FC-A4D0-FED9E2AB96C9Q34361823-251F3902-548C-4CB6-AF78-1253550CE8BCQ34466367-008D8771-4F5C-4EF0-B9FD-7F8769118E45Q34546893-896A85BD-4EB1-46E8-958D-C17E5546B486Q34583829-5EE8B6B7-FFA5-4BF8-973B-0107E68708F9Q34704221-57B552A1-4083-4D77-B7F5-75049CF3A2DCQ34736000-EB0A28A7-DAF4-4B90-AA13-AE6A1271C764Q35008078-BDC23FCB-E45A-4AC4-82EB-50FB977BC6A7Q35008833-85A741AF-8BE0-40B1-895D-074BD42043A8Q35131606-E136637D-48D7-4C5F-B6ED-67A62B63B599Q35179276-6E81D72B-6EC1-458D-ACFB-D0899499DDEB
P2860
The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@ast
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@en
type
label
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@ast
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@en
prefLabel
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@ast
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@en
P2093
P2860
P356
P1433
P1476
The SR splicing factors ASF/SF ...... ropomyosin alternative exon 6A
@en
P2093
Expert-Bezançon A
Stévenin J
P2860
P304
P356
10.1093/EMBOJ/16.7.1772
P407
P577
1997-04-01T00:00:00Z